Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft

Journal of the American Society of Nephrology

Volumn 12, Issue 9, 2001, Pages 1937-1946

  Noris, M ^a   Azzollini, N ^a   Pezzotta, A ^a   Mister, M ^a   Benigni, A ^a   Marchetti, G ^a   Gagliardini, E ^a   Perico, N ^a   Remuzzi, G ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CREATININE; CYCLOSPORIN A; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GRAFT SURVIVAL; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034863150     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Chronic transplant rejection: Magnitude of the problem and pathogenetic mechanisms
2. Overview
3. Improved graft survival after renal transplantation in the United States, 1988 to 1996
4. Chronic rejection: An undefined conundrum
5. Both alloantigen-dependent and -indepedent factors influence chronic allograft failure
6. Chronic vascular rejection of the heart and the kidney - Have rational treatment options emerged?
7. Protecting single-kidney allografts from long-term functional deterioration
8. The role of anti-HLA anti-bodies in heart transplantation
9. Reversibility of chronic renal allograft rejection: Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury
10. Chronic rejection and chronic cyclosporin toxicity in renal allografts
11. Antigen-independent determinants of late renal allograft outcome: The role of renal mass
12. Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection
13. Evidence that recipient CD8+ T cell depletion does not alter development of chronic vascular rejection in a rat heart allograft model
14. Nephron underdosing: A programmed cause of chronic renal allograft failure
15. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism
16. Antihypertensive drug treatment in chronic renal allograft rejection in the rat
17. Peripheral donor leukocytes prolong survival of rat renal allografts
18. Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats
19. Protein measurements with the Folin phenol reagent
20. A rapid colorimetric method for the determination of inulin in plasma and urine
21. The renal clearance of substituted hippuric acid derivatives and other aromatic acid in dog and man
22. Some statistical methods useful in circulation research
23. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts
24. Mycophenolate mofetil inhibits lymphocyte binding and the up-regulation of adhesion molecules in acute rejection of rat kidney allografts
25. Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice
26. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney
27. Candesartan cilexetil reduces chronic renal allograft injury in Fisher→Lewis rats
28. Renal allograft protection with losartan in Fisher→Lewis rats: Hemodynamics, macrophages, and cytokines
29. Physiological and structural responses to chronic experimental renal allograft injury
30. Glomerular capillary pressures in long-surviving rat renal allografts
31. Angiotensin receptor blockers in chronic renal disease: The promise of a bright clinical future
32. Pathophysiology of progressive nephropathies
33. Influence of the angiotensin system on endothelial and smooth muscle cell migration
34. Angiotensin II as a renal growth factor
35. Renal injury from angiotensin II-mediated hypertension
36. Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs
37. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model: A comparative study with captopril
38. Angiotensin II regulates cellular immune response through a calcineurin-dependent pathway
39. Cyclosporine A and azathioprine are equipotent in chronic kidney allograft rejection
40. Cyclosporine-induced renal dysfunction in experimental animals and humans